Syngen Biotech Co (ROCO:8279) Short-Term Debt: NT$112 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:8279 Syngen Biotech Co Ltd ROCO:8279
90 GF Score
Price NT$80.50
GF Value NT$133.11
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Syngen Biotech Co Short-Term Debt?

Syngen Biotech Co ROCO:8279 90 Short-Term Debt is NT$112 Mil as of Jun. 2026. GuruFocus rates ROCO:8279 with a GF Score™ of 90/100 and a GF Value™ of NT$133.11 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Syngen Biotech Co's Short-Term Debt for the quarter that ended in Jun. 2026 was NT$112 Mil.

Syngen Biotech Co's quarterly Short-Term Debt declined from Dec. 2025 (NT$149 Mil) to Mar. 2026 (NT$0 Mil) but then increased from Mar. 2026 (NT$0 Mil) to Jun. 2026 (NT$112 Mil).

Syngen Biotech Co's annual Short-Term Debt declined from Dec. 2023 (NT$282 Mil) to Dec. 2024 (NT$206 Mil) and declined from Dec. 2024 (NT$206 Mil) to Dec. 2025 (NT$149 Mil).

Syngen Biotech Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Syngen Biotech Co Short-Term Debt Related Terms

Syngen Biotech Co Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Syngen Biotech Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Syngen Biotech Co Short-Term Debt Chart

Syngen Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 112.03 415.75 282.31 205.90 149.43

Syngen Biotech Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 216.04 260.60 149.43 0.00 111.93
ROCO:8279
90GF Score
Syngen Biotech Co Ltd ROCO:8279
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of NT$112 Mil mean?
Syngen Biotech Co (ROCO:8279) has a Short-Term Debt of NT$112 Mil as of Jun. 2026.
Is Syngen Biotech Co's Short-Term Debt too high?
Syngen Biotech Co's current Short-Term Debt is NT$112 Mil. Overall, Syngen Biotech Co has a GF Score™ of 90/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Syngen Biotech Co's Short-Term Debt compare to VRTX and REGN?
Syngen Biotech Co's Short-Term Debt of NT$112 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Biotechnology company?
A good Short-Term Debt depends on the Biotechnology industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Syngen Biotech Co's current Short-Term Debt is NT$112 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Syngen Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Syngen Biotech Co (ROCO:8279) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$133.11, compared to a current price of NT$80.50 — trading 39.5% below its estimated fair value. The current Short-Term Debt is NT$112 Mil. Syngen Biotech Co's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Syngen Biotech Co (ROCO:8279), the current Short-Term Debt is NT$112 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Syngen Biotech Co (ROCO:8279) Overvalued in 2026?

Based on GuruFocus' analysis, Syngen Biotech Co stock appears to be undervalued. The current stock price of NT$80.50 is trading 39.5% below its estimated GF Value™ of NT$133.11. GuruFocus considers Syngen Biotech Co to be Significantly Undervalued.

Key valuation signals for ROCO:8279:

  • Short-Term Debt: NT$112 Mil
  • GF Value™: NT$133.11 vs. price of NT$80.50 (39.5% below fair value)
  • GF Score™: 90/100 with 3 warning signs

No single metric tells the full story. See the ROCO:8279 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Syngen Biotech Co Business Description

Address Building A, NO.154, Kai-Yuan Road, Xinying District, Tainan, TWN, 73055
Syngen Biotech Co Ltd is a biotechnology company. It is engaged in the manufacturing, sales, and trading of microbial pharmaceutical raw materials. It also provides the design and development of health food and biochemical nutrition. The company's products include pharmaceutical ingredients, nutritional ingredients, biology fermentation products, biology agriculture and aquaculture products.
90GF Score

Get the complete analysis for ROCO:8279

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$80.50
Price
NT$133.11
GF Value